Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 21, 2025
MAPK Pathway-Activating Alteration and Immunotherapy Efficacy in Squamous Cell Lung Carcinoma: Results from the Randomized, Prospective SQUINT Trial
Federico Cappuzzo, Biagio Ricciuti, Angelo Delmonte, et al.
Scientific Reports
|
September 8, 2017
Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt study
Laura Pizzuti, Paolo Marchetti, Clara Natoli, et al.
Journal of Translational Medicine
|
February 7, 2018
Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy
Elisa Melucci, Beatrice Casini, Livia Ronchetti, et al.
Cancer Research
|
September 8, 2019
Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal Adenocarcinoma
Carla Mottini, Hideo Tomihara, Diego Carrella, et al.
Clinical Lung Cancer
|
March 1, 2021
Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non-Small-Cell Lung Cancer
Vanesa Gregorc, Luca Mazzarella, Chiara Lazzari, et al.
Diagnostics (Basel, Switzerland)
|
February 25, 2023
An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples
Paolo Bironzo, Francesco Pepe, Gianluca Russo, et al.
Cancers
|
August 10, 2024
DNA Damage Response in Early Breast Cancer: A Phase III Cohort in the Phobos Study
Eriseld Krasniqi, Cristiana Ercolani, Anna Di Benedetto, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 23, 2013
External Quality Assessment (EQA) program for the preanalytical and analytical immunohistochemical determination of HER2 in breast cancer: an experience on a regional scale
Irene Terrenato, Vincenzo Arena, Sara Pizzamiglio, et al.
JAMA Oncology
|
May 22, 2025
Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non-Small Cell Lung Cancer
Biagio Ricciuti, Francesca Fusco, Alissa Cooper, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 20, 2025
A decalogue of Molecular Tumor Board (MTB) recommendations from the CAN.HEAL Consortium
Gennaro Ciliberto, Ruggero De Maria, Patrizio Giacomini, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 21, 2025
MAPK Pathway-Activating Alteration and Immunotherapy Efficacy in Squamous Cell Lung Carcinoma: Results from the Randomized, Prospective SQUINT Trial
Federico Cappuzzo, Biagio Ricciuti, Angelo Delmonte, et al.
Scientific Reports
|
September 8, 2017
Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt study
Laura Pizzuti, Paolo Marchetti, Clara Natoli, et al.
Journal of Translational Medicine
|
February 7, 2018
Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy
Elisa Melucci, Beatrice Casini, Livia Ronchetti, et al.
Cancer Research
|
September 8, 2019
Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal Adenocarcinoma
Carla Mottini, Hideo Tomihara, Diego Carrella, et al.
Clinical Lung Cancer
|
March 1, 2021
Prospective Validation of the Italian Alliance Against Cancer Lung Panel in Patients With Advanced Non-Small-Cell Lung Cancer
Vanesa Gregorc, Luca Mazzarella, Chiara Lazzari, et al.
Diagnostics (Basel, Switzerland)
|
February 25, 2023
An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples
Paolo Bironzo, Francesco Pepe, Gianluca Russo, et al.
Cancers
|
August 10, 2024
DNA Damage Response in Early Breast Cancer: A Phase III Cohort in the Phobos Study
Eriseld Krasniqi, Cristiana Ercolani, Anna Di Benedetto, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 23, 2013
External Quality Assessment (EQA) program for the preanalytical and analytical immunohistochemical determination of HER2 in breast cancer: an experience on a regional scale
Irene Terrenato, Vincenzo Arena, Sara Pizzamiglio, et al.
JAMA Oncology
|
May 22, 2025
Neoadjuvant PD-1 and PD-L1 Blockade With Chemotherapy for Borderline Resectable and Unresectable Stage III Non-Small Cell Lung Cancer
Biagio Ricciuti, Francesca Fusco, Alissa Cooper, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 20, 2025
A decalogue of Molecular Tumor Board (MTB) recommendations from the CAN.HEAL Consortium
Gennaro Ciliberto, Ruggero De Maria, Patrizio Giacomini, et al.
Page
of 9